PlantForm | Invest

Invest in PlantForm

PlantForm is a private Canadian biotech company established in 2008. Investment opportunities are available as PlantForm commercializes its proprietary vivoXPRESS® technology platform for plant-made pharmaceuticals.

The company has secured financing of $8 million to date from founders, management, angel investors, and U.K.-based Atlantic Assets Trust. PlantForm is currently seeking a Series A round of financing of up to $10 million.

For more information, please contact:

Don Stewart
President and CEO

Why Invest?

"PlantForm is ideally positioned to meet the fast-growing demand for affordable antibody medicines: it has a novel, versatile and scalable manufacturing platform with an excellent management team that can execute on a well thought-out plan."

Peter Pekos
PlantForm investor
President & CEO, Dalton Chemical Laboratories Inc.

Rounded Corners